Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3985319
Max Phase: Preclinical
Molecular Formula: C47H54ClN7O6S
Molecular Weight: 880.51
Molecule Type: Small molecule
Associated Items:
ID: ALA3985319
Max Phase: Preclinical
Molecular Formula: C47H54ClN7O6S
Molecular Weight: 880.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCCCN5CCCC5)c([N+](=O)[O-])c4)c(Oc4cccc5[nH]ccc45)c3)CC2)=C(c2ccc(Cl)cc2)C1
Standard InChI: InChI=1S/C47H54ClN7O6S/c1-47(2)19-17-34(40(31-47)33-9-11-35(48)12-10-33)32-53-25-27-54(28-26-53)36-13-15-39(45(29-36)61-44-8-5-7-41-38(44)18-21-50-41)46(56)51-62(59,60)37-14-16-42(43(30-37)55(57)58)49-20-6-24-52-22-3-4-23-52/h5,7-16,18,21,29-30,49-50H,3-4,6,17,19-20,22-28,31-32H2,1-2H3,(H,51,56)
Standard InChI Key: IIKYWYNMTFUCFU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 880.51 | Molecular Weight (Monoisotopic): 879.3545 | AlogP: 9.32 | #Rotatable Bonds: 15 |
Polar Surface Area: 153.15 | Molecular Species: ZWITTERION | HBA: 10 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.15 | CX Basic pKa: 9.32 | CX LogP: 7.82 | CX LogD: 7.04 |
Aromatic Rings: 5 | Heavy Atoms: 62 | QED Weighted: 0.05 | Np Likeness Score: -1.08 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):